INS and endothelial dysfunction: ApoC-III production is stimulated by insulin resistance, but ApoC-III itself amplifies insulin resistance through endothelial cells (ECs) [46] by contributing to an impaired insulin signaling and endothelial dysfunction, acting as a key driver of the diabetic dyslipidemia [46].